‘A landmark decision': advocates celebrate reform of health screening task force
Women in their 40s in Ontario can now book a mammogram without needing a doctor's referral. (THE CANADIAN PRESS/AP-Kimberly P. Mitchell/Detroit Free Press via AP)
Advocates and doctors are applauding the recently released external expert panel report on the Canadian Task Force on Preventive Health Care, which calls for modernization and reform of the task force.
Some of the recommendations to modernize the task force include ensuring preventive health care remains up to date with evolving scientific data and applying it to guidelines in a timely manner, the inclusion of equity-centred perspectives, patient involvement, and collaboration with pre-existing guidelines to help eliminate disparities across the country.
'This is great news,' said Dr. Anna Wilkinson, a family physician and general practitioner-oncologist at The Ottawa Hospital, in a phone interview with CTVNews.ca.
'They are saying that we need to modernize the task force, and I think that's because we're recognizing that we are kind of behind the times on our cancer screening guidelines and many of our other preventive health care guidelines.'
Task force halted amid criticism
The task force, which is responsible for developing preventive health guidelines like cancer screening across Canada, is an independent body that develops clinical guidelines for family doctors about screening and prevention measures for cancer and other diseases.
The task force's work was halted last year following criticism of its proposed incoming breast cancer screening guidelines, which did not recommend mammography screening begin at age 40.
Instead, it upheld its 2018 guidelines recommending screening begin at age 50, despite growing evidence and calls from numerous medical experts and organizations urging earlier screening in response to rising breast cancer rates among younger women.
This prompted then-Health Minister Mark Holland to request that the Public Health Agency launch an external expert review panel, which began in October 2024, to recommend changes and improvements to the task force's structure, governance, and methodology for developing the guidelines.
Dr. Wilkinson, one of the medical experts who advised the external review panel, says she is pleased the report acknowledges the need to modernize the task force.
'We cannot afford economically as a health system to not be,' she said.
'We know that it's so much cheaper to deal with cancers when they're smaller, we know the outcomes are better, the cost to our health-care system is better.'
'I think one of the ways forward for a health-care system is to do preventive care more effectively. (…) This is a high-level view of how we might do that, so I look forward to seeing how it gets implemented.'
With implementation of the recommendations currently underway, Health Minister Marjorie Michel has requested that the Public Health Agency of Canada have the task force operational by April 2026.
'Landmark change'
Kimberly Carson, CEO of Breast Cancer Canada, was one of many advocates calling for the incoming breast cancer guidelines to recommend screening begin at age 40 rather than 50.
Carson, who met with Holland and the external expert review panel, is content with the report's findings.
'It's going to be fantastic for Canadians,' Carson told CTVNews.ca in a phone interview.
'We know that if we catch breast cancer early, it's better for the patient, it's better for the health-care system, it costs less, there's less financial toxicity for the patients and a better cure rate. (…) It changes the paradigm for Canadian patients.'
The task force began meeting on the upcoming breast cancer guidelines in May 2023.
For two years, Breast Cancer Canada advocated for the inclusion of subject matter experts in guideline development, the timely integration of the latest data, and the incorporation of patient perspectives.
With the report acknowledging all these points, Carson says she is satisfied that the sustained mobilization efforts have yielded results.
'It's such a landmark change in a landmark decision,' Carson said.
The Canadian Cancer Society, which also stated in a media release its approval of the report, also had its recommendations reflected in the findings.
Some of these recommendations echo those of Breast Cancer Canada, including the inclusion of cancer experts, patient perspectives, and staying current with evolving perspectives, experiences and scientific evidence.
'Once they reform the task force and it becomes functional in April, we would hope that they would immediately take a look at the screening guidelines for breast cancer,' Carson added.
In addition to the 2018 breast cancer guidelines, the current cancer screening guidelines for other cancers — like colon cancer (2016), prostate cancer (2014), and cervical cancer (2013) — are also due for updates, Dr. Wilkinson notes.
She says this report is a 'critical step' towards modernizing all of Canada's screening guidelines.
'In today's strained health-care environment, optimizing preventive care is essential to making the most of our limited resources,' she said in an email to CTVNews.ca. 'The integration of diverse and evolving evidence, equitable care and ongoing evaluation pave the way for agile, 'living' guidelines that keep pace with scientific advancements.
'This approach will help ensure Canada no longer relies on cancer screening recommendations that are over a decade old.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
2 hours ago
- Globe and Mail
The hidden toll of chronic migraine on workers and companies
This is the weekly Work Life newsletter. If you are interested in more careers-related content, sign up to receive it in your inbox. One of Maya Carvalho's worst migraines lasted nine days. 'I was completely bedridden,' she says. 'My pain was so intense it felt like if I moved my head an inch, it would crack open.' She had been thriving in a high-powered role at a multi-national beauty company in New York City when migraine suddenly entered her life. 'It hit me out of the blue,' she says. 'I hadn't had migraines before, not even as a kid.' Almost overnight, what started as one attack escalated into chronic migraine – defined as 15 or more migraine days per month. 'I knew I couldn't perform at the level I wanted to. And there was no conversation about accommodations, no awareness that migraine was a disease. So I had to walk away [from my job],' she says. 'It was devastating.' A costly, invisible disease Today, chronic migraine affects an estimated 1-2.2 per cent of the global population while migraines affect 12 to 15 per cent, with women more likely to be affected. According to the World Health Organization, a day with severe migraine is as disabling as a day with quadriplegia. That's why Toronto-based Ms. Carvalho, who is the founder of the Canadian Migraine Society, is passionate about helping workplaces understand the full weight of this invisible neurological disease. Migraine is often more than head pain. It can involve light and sound sensitivity, nausea, vomiting and vertigo. 'Each person has their own constellation of symptoms,' Ms. Carvalho says. 'But the pain is intense. I've had women tell me it's worse than childbirth.' The productivity paradox From a business perspective, migraine is a silent disruptor. Ms. Carvalho says employers often focus on absenteeism, but presenteeism – when employees are present at work, but not functioning at full capacity because of pain or other issues – may be even more costly. '[Presenteeism] affects productivity, and often leads to isolation and mental health struggles,' she says. Yet, with a few simple, low-cost changes, workplaces can make a difference. Scent-free policies, anti-glare screens, quiet spaces and flexible work options can be game-changers, she says. 'Even just letting someone work from home one day a week can help,' she says. Ms. Carvalho also urges HR teams to review their benefits plans. 'Making sure that the newest migraine treatments are covered can prevent the disease from escalating,' she says. 'We wouldn't have to keep watching women leave the workforce at their peak.' Workplace equity at stake For Ms. Carvalho, supporting people with migraine is about more than healthcare – it's about fairness. 'This is a work equity issue,' she says. 'Supporting those with chronic migraine isn't charity. It's smart business.' Her message to those experiencing chronic migraine is clear: 'You are not alone, and there is absolutely hope for you. We'll walk this journey with you – it doesn't have to be this hard.' 30 per cent That's how many of the menu items Starbucks plans to cut, while adding new trendier offerings such as protein cold foam, which offers 15 grams of banana flavoured, muscle-building goodness. Read more Feedback is key to employee development but, according to this article, it's effectiveness depends on timing. Research suggests mornings are best, as most people are more alert and receptive earlier in the day because of natural circadian rhythms, which influence sleep-wake cycles, hormone production and body temperature. Read more 'If someone comes to me and says they're raising a million dollars, I'll ask right away, 'How long does that get your company through?' If they cannot tell me that it's around 24 months, or even a bit more, we have to restructure the round completely,' says Mary Dimou, general partner at Nàdarra Ventures. In this article, capital investment pros share how you can raise capital during uncertain times, emphasizing proactive communication, strategic timing and pivoting your message when it's not landing. Read more 'Canadian‑made' isn't just a nice‑to‑have; it's a smart strategy. More companies are going local to connect with consumers who care about ethics and sustainability. The bonus? Leaner supply chains, honest branding and a tighter bond with customers. Read more
CBC
2 hours ago
- CBC
Hopes of fatherhood: UBC scientists on frontier of high-tech male infertility research
Social Sharing A team of researchers at the University of British Columbia (UBC) is using artificial intelligence in an effort to detect hard-to-find sperm and 3D bioprinting technology with the ultimate goal of growing sperm in the lab — technologies they say could eventually help men with infertility become parents. The research, led by Dr. Ryan Flannigan, a urologist and associate professor at UBC, is aimed at addressing a "severe form" of male infertility called non-obstructive azoospermia (NOA), in which the body produces little to no sperm. It's a condition that affects about one in 100 men, many of whom are survivors of childhood cancer, according to Flannigan. "There's a big problem with infertility: it's so common," he told CBC's The Early Edition. "Something that I see time and time again is just how much of an emotional toll having challenges with infertility is." According to a UBC media release, about two thirds of male pediatric cancer survivors will face infertility in adulthood, due to the effects of radiation or chemotherapy. Globally, one in six couples struggles to conceive, and male infertility, broadly, plays a role in about half of those cases. AI to detect rare sperm Currently, the only treatment for NOA involves surgically extracting testicular tissue and searching for hard-to-find sperm under a microscope — a tedious process, says Flannigan, that can take hours and still might end in failure. "It's ... looking for a needle in a haystack," he says. "Right now, we're able to find sperm about 50 per cent of the time. We ideally need to find at least one sperm per each egg, among millions of other cells, which takes hours." To improve the odds, Flannigan says he and UBC engineering professor Hongshen Ma have developed an AI-powered tool that scans microscopic images to flag viable sperm for use in in vitro fertilization (IVF). The technology is still a long way from being available for people struggling with male infertility — Flannigan expects clinical trials for the AI tool could begin within the next three to five years. Lab-grown sperm for those without options But for people who produce no sperm at all, including children who undergo cancer treatment before puberty and are unable to store sperm, a more experimental avenue is underway: lab-grown sperm. In what the UBC media release calls a world-first, Flannigan and team have bioprinted a model of human testicular tissue using stem cells and a specialized gel-like "bio-ink." The printed structure replicates the tiny tubes in the testes where sperm are normally produced. These bioprinted 'mini testicles' are encased in a special gel filled with specific nutrients and vitamins to help them mature. According to researchers, some of the cells have already begun showing signs consistent with the early stages of puberty — "a time when sperm production starts occurring in the human body." "What we're trying to do with 3D bioprinting is recreate what's happening in a healthy testicle as accurately as we can," said Flannigan. "If we can determine what the cells need to progress through all the phases of sperm production, we can use that knowledge to figure out how to create sperm for a patient with NOA," says Dr. Flannigan. The work is being supported by experts in microfluidics — a system that manipulates a small amount of fluids — and cancer biology at UBC and the University of Victoria, who are helping identify the molecular conditions required for sperm to develop. Still, researchers acknowledge there are significant challenges ahead. According to the UBC release, sperm production is a "highly complicated process" involving multiple cell types, complex anatomical structures, making it a task that demands collaborative, multidisciplinary research. 'Life-changing' potential, but questions remain Laura Spencer, a fertility coach in Vancouver, has experienced the emotional toll of infertility first-hand in her own family. "I've gone through infertility — male factor infertility in particular — and it's devastating," she told CBC News. "There's nothing quite like it." She said this latest development in treating male infertility could potentially be life-changing for many couples. WATCH | An at-home test is in the works to measure male fertility: An at-home test is in the works to measure male fertility 3 months ago Duration 1:46 Researchers at the University of Waterloo are working on an at-home test, which is a cheaper alternative to other tests. It usually involves examining the sperm under a microscope in a lab, but this one will allow people to check right at home. Sushanta Mitra, a professor of mechanical and mechatronics engineering, is one of the researchers behind the study. "This shows a lot of promise for people who might not have the ability to try and conceive … they might actually be able to have a baby." Spencer says male infertility remains a taboo subject, despite being a factor in about half of all couples struggling to conceive. She hopes this research not only opens new medical doors, but also breaks down stigma. "There is a lot of shame and sometimes guilt around that," she said. "I'm always grateful when the conversation turns to infertility and when it's normalized." "There will definitely need to be education around this," she added. "We don't know what the long term consequences are of this technology. Are there any birth defects that are possible? What about when they grow up? Like we don't know. This is just so new." As for concerns about the safety of AI or stem cell-based procedures, Flannigan says the research team is taking a cautious approach.
CBC
3 hours ago
- CBC
Alberta government to increase prescription costs for seniors for first time in 31 years
Social Sharing For the first time in more than three decades, the Alberta government is raising prescription costs for some seniors and Albertans under non-group coverage. Beginning July 1, the maximum co-payment per prescription will gradually increase by $10 over 10 months, from $25 to $35 at a rate of $1 per month. The increase will be fully implemented by April 1, 2026. It's the first time the cost has increased since 1994. Alberta seniors face rising drug prescription costs 2 days ago Duration 2:32 The province is raising out-of-pocket prescription costs for seniors and Albertans under non-group coverage by $10. According to the government, the hike is necessary to keep pace with a seven per cent annual increase in funding for these programs. The province says the hike is necessary to keep pace with rising costs, with the cost of providing coverage for seniors and those in the non-group program increasing by about seven per cent annually. The majority of Alberta seniors will still pay less than seniors in most other provinces, the province said. But for seniors like Marilyn Wieler, 83, the added expense represents more than a minor adjustment. "It's a hardship, people weren't prepared for this. And why the seniors?" Said Wieler, a volunteer at the Mill Woods Seniors and Multicultural Centre. "We're on a limited income. Nobody's giving us extra money, and now they hit us with this. "When you really need it a lot of people can't afford it. That's really unjust." Alberta's non-group coverage provides prescription drug insurance to residents under 65 who aren't covered by an employer or private plan. If the co-payments increased at the same rate of inflation, seniors would be paying $48, according to the government. "The cost to provide this coverage is rising significantly due to factors such as increasing drug prices, population growth, and an aging population. To maintain the long-term sustainability of these programs and keep medications accessible, an increase to the maximum co-payment for seniors is necessary," said the office of the minister of Primary and Preventative Health Services in a statement to CBC. Change adds stress, advocates say Currently, there are about 760,000 Albertans aged 65 and older that have senior drug coverage, though only about five per cent pay the maximum co-payment, the province said. Among the roughly 75,000 Albertans with non-group coverage, about 18 per cent hit the maximum. Low-income seniors can apply for assistance through the province's special needs assistance for seniors program, the province said. Still, advocates and seniors say the change adds stress, especially for those managing multiple prescriptions. "We know that means some people won't access the medications they need. They'll end up sicker, they'll end up in our hospital system and it'll cost us more. That's the story of drugs," said Chris Gallaway, the executive director at Friends of Medicare. "Affordability is a big concern for seniors and everyone, but especially seniors on a fixed income. And by doing something like this, we know it means people won't be able to access the drugs they need. And it means that Albertans will be paying more and more out of pocket for healthcare that should be covered," he said. Rosemary Anderson, another senior at the Millwoods Centre, said she worries about the impact on low-income people. "You choose not to take your diabetic, you choose not to take your blood pressure because you can't afford it" "For wealthy people, $10 is nothing a month, but for a lot of people it is." The cost of administering the seniors and non-group drug programs in 2023-24 was around $1.3 billion. That figure is projected to rise by $194 million to approximately $1.494 billion by 2026-27. The number of seniors in Alberta is expected to nearly double to 1.4 million by 2051. In a statement, Sarah Hoffman, the Opposition health critic, criticized the move. "Because this increase is per prescription, more seniors will be forced into making a choice – medicine or food, or rent, or insurance, or utilities bills, all of which have increased in cost due to this incompetent and cruel UCP government," Hoffman said. "In the end senior's health will suffer, they will need more care because they can't afford medication, and the added strain on the entire health-care system will impact all Albertans."
